Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-011612

Chief Commercial Officer sold 56,973 shares at $2.55 ($145,281)

From the SEC's structured data for this filing

Trades in this filing

Evanson Jeff · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-12 Sale : show line 1 in the form −56,973 $2.55 $145,281 1,150,484 D
Open-market sales · 56,973 sh · avg $2.55 · $145,281
Loading xslF345X03/doc4.xml…